1. Home
  2. NAII vs ENLV Comparison

NAII vs ENLV Comparison

Compare NAII & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • ENLV
  • Stock Information
  • Founded
  • NAII 1980
  • ENLV 2005
  • Country
  • NAII United States
  • ENLV Israel
  • Employees
  • NAII N/A
  • ENLV N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • ENLV Health Care
  • Exchange
  • NAII Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • NAII 23.7M
  • ENLV 20.7M
  • IPO Year
  • NAII 1987
  • ENLV 1995
  • Fundamental
  • Price
  • NAII $2.72
  • ENLV $0.92
  • Analyst Decision
  • NAII
  • ENLV Strong Buy
  • Analyst Count
  • NAII 0
  • ENLV 2
  • Target Price
  • NAII N/A
  • ENLV $10.00
  • AVG Volume (30 Days)
  • NAII 13.0K
  • ENLV 62.6K
  • Earning Date
  • NAII 05-13-2025
  • ENLV 06-13-2025
  • Dividend Yield
  • NAII N/A
  • ENLV N/A
  • EPS Growth
  • NAII N/A
  • ENLV N/A
  • EPS
  • NAII N/A
  • ENLV N/A
  • Revenue
  • NAII $121,853,000.00
  • ENLV N/A
  • Revenue This Year
  • NAII N/A
  • ENLV N/A
  • Revenue Next Year
  • NAII N/A
  • ENLV N/A
  • P/E Ratio
  • NAII N/A
  • ENLV N/A
  • Revenue Growth
  • NAII N/A
  • ENLV N/A
  • 52 Week Low
  • NAII $2.57
  • ENLV $0.81
  • 52 Week High
  • NAII $7.26
  • ENLV $1.84
  • Technical
  • Relative Strength Index (RSI)
  • NAII 34.21
  • ENLV 44.97
  • Support Level
  • NAII $2.57
  • ENLV $0.86
  • Resistance Level
  • NAII $3.20
  • ENLV $0.91
  • Average True Range (ATR)
  • NAII 0.33
  • ENLV 0.06
  • MACD
  • NAII -0.03
  • ENLV 0.00
  • Stochastic Oscillator
  • NAII 15.63
  • ENLV 47.06

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: